SEC Form 4 · accession 0001209191-16-134948
Horizon Pharma plc · HZNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey W Sherman
Officer — EVP and Chief Medical Officer
Period of report
Aug 2, 2016
Accepted (ET)
Aug 2, 2016 · 4:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Aug 2, 2016 | S | 2,900 | $20.00 | D | 159,250 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2015.
- F2Includes 2,050 ordinary shares of the Issuer acquired by the reporting person on June 1, 2016 pursuant to an employee stock purchase program.